FDA Ðû²¼Á½·ÝÖ¸ÄÏΪҩƷÉêÇëµÄ¸ßÖÊÁ¿µÝ½»Ìṩ½¨Òé
Ðû²¼Ê±¼ä£º2018-09-30
ä¯ÀÀ´ÎÊý£º1479
×÷Õß:ʶÁÖ
ÃÀ¹úFDA ÓÚ 9 Ô 24 ÈÕÐû²¼ÁË¡¶ANDA µÝ½» ¡ª ÄÚÈݺÍÃûÌá·¶¨¸åÖ¸ÄÏ¡£Õâ·Ý³¤´ï 32 Ò³µÄÖ¸ÄÏ±È 2014 ÄêµÄÖ¸Äϲݰ¸¸üÏêϸ£¬ÌṩÁ˶ÔÎļþijЩ²¿·ÖºÍÒªÇóµÄÀ©Õ¹ËµÃ÷¡£Í¬Ê±»¹Ðû²¼ÁË¡¶NDA ºÍ BLA ÓÅÒìÉóÆÀ¹ÜÀíÔÔòºÍʵ¼ù¡·Ö¸Äϲݰ¸£¬Ïò¹¤Òµ½çºÍÉóÆÀÊÂÇéÖ°Ô±ÏÈÈÝÁËÔÚÐÂÒ©ÉóÆÀÖÐÉóÆÀÖ°Ô±µÄÖ°ÔðÒÔ¼°ÓÅÒìÉóÆÀ¹ÜÀíÔÔòºÍʵ¼ù£¨GRMP£©¡£
ÕâÁ½·ÝÖ¸ÄϵÄÐû²¼ÊÇFDA Ò©Æ·¾ºÕùÐж¯ÍýÏëµÄÒ»²¿·Ö£¬FDA ¾Ö³¤ Scott Gottlieb
ÌåÏÖ£¬¡°×÷ΪÎÒÃÇÒ»Ö±Æð¾¢½µµÍÒ©¼ÛºÍ¸ÄÉÆÁ¢ÒìÒ©¿É¼°ÐÔÊÂÇéµÄÒ»²¿·Ö£¬FDA Ðû²¼Á½·ÝÖ¸ÄÏÎļþÐÖú FDA ÊÂÇéÖ°Ô±ºÍÐÐÒµ£¬È·±£ÐÂÒ©ÉóÆÀ³ÌÐòºÍ·ÂÖÆÒ©ÉóÆÀ³ÌÐò¹ÜÀíµÄÒ»Ö¡¢Í¸Ã÷ºÍ¸ßЧ¡£¡±
ANDA µÝ½»ÄÚÈݺÍÃûÌö¨¸åÖ¸ÄÏ
ANDAµÝ½»¶¨¸åÖ¸ÄÏÖ¼ÔÚ×ÊÖúÉêÇëÈË×¼±¸ÍêÕûµÄ¡¢¿ÉµÝ½»µÄ ANDA ÉêÇë¡£¶¨¸åÖ¸ÄÏÏêϸ˵Ã÷ÎúÈËÓÃÒ©ÉêÇëͨÓÃÊÖÒÕÎļþ£¨CTD£©ÃûÌÃÖÐÿ²¿·ÖµÄÐÅÏ¢£¬²¢¸ø³öÁËFDA Ðû²¼µÄÖ§³ÖÐÔÖ¸ÄÏÎļþºÍ½¨Ò飬ÒÔ×ÊÖúÉêÇëÈË×¼±¸Æä ANDA µÝ½»¡£ÔÚ˼Á¿ÁË¶Ô 2014 ÄêÖ¸Äϲݰ¸°æ±¾µÄ¹«ÖÚ·´ÏìÒâ¼ûÖ®ºó£¬FDA ÔÚ¶¨¸åÖ¸ÄÏÖÐ×öÁËÊÖÒÕ³ÎÇå²¢¸üÐÂÁ˲ο¼Îļþ¡£´ÓÀúÊ·ÉÏ¿´£¬ÐèÒªÒ»¼þ ANDA ÐèÒªËÄÂÖÉóÆÀÖÜÆÚ²Å»ª»ñµÃÅú×¼£¬¸Ã¶¨¸åÖ¸ÄÏ¡°Í¨¹ýÏòÐÐÒµ³ÎÇåÔõÑù´ÓÒ»×îÏȾÍÌá½»ÍêÕû¡¢¸ßÖÊÁ¿µÄÉêÇëÀ´ïÔÌÉóÆÀÂִΡ±¡£
Ö¸ÄÏ¶Ô eCTD µÄÿ²¿·Ö¶¼Óн¨Ò飬ֵµÃ»¨Ê±¼ä×ÐϸÔĶÁ¸ÃÖ¸ÄÏ£¬²¢×¢ÖØÓëÖ¸Äϲݰ¸Ïà±ÈµÄת±ä , ÒÔ×ÊÖúÆóÒµ¸üºÃµØ×éÖ¯¿ÉÒÔÔÚ¡°Ê×ÂÖ¡±»ñÅúµÄ ANDA¡£Ê¶ÁÖ½«ÓÚ½üÆÚÍÆ³ö¸Ã¶¨¸åÖ¸ÄÏÓëÀúÊ·°æ±¾µÄ±ÈÕÕ½â¶Á¼°·Òë¸å¡£
NDA ºÍ BLA ÓÅÒìÉóÆÀ¹ÜÀíÔÔòºÍʵ¼ùÖ¸Äϲݰ¸
Õâ·Ý8 Ò³µÄÖ¸Äϲݰ¸ÌÖÂÛÁË FDA ÉóÆÀÖ°Ô±ÔÚ¹ÜÀíÉóÆÀ³ÌÐòÊÂÇéÖеÄÖ°Ô𣬲¢Ö¸³öÉêÇëÈËÔõÑùͨ¹ýÓÅÒìÉóÆÀ¹ÜÀíÔÔòºÍʵ¼ù£¨GRMP£©Ö§³Ö¸ßЧµÄÐÂÒ©»òÉúÎïÖÆÆ·ÉêÇëÉóÆÀ³ÌÐò¡£Ö¸Äϲݰ¸ÌåÏÖ£¬¡°GRMPµÄÄ¿µÄÊÇÈ·±£ÒÔÒ»Öº͸ßЧµÄ·½·¨¹ÜÀíÉóÆÀ³ÌÐò , ´Ó¶øïÔÌÅú×¼ËùÐèµÄÉóÆÀÖÜÆÚÊý£¬²¢Ìá¸ß»¼Õß¶ÔÖ÷ÒªÖÎÁÆÒ©µÄʵʱ»ñÈ¡¡£¡±Ö¸Äϲݰ¸°üÀ¨»ù±¾¼ÛÖµ£¨°üÀ¨ÎÊÔðÖÆ¡¢ÏàͬºÍÒ»ÖÂÐÔ£© , ÔËÓªÔÔò£¨ÊµÊ±ÆµÈÔµÄÉóÆÀÍŶÓÐ×÷¹ØÓÚÓÅÒìÉóÆÀ¹ÜÀíÖÁ¹ØÖ÷Òª£©ÒÔ¼°¸ü¶à¹ØÓÚвúÆ·ÉóÆÀ³ÌÐòµÄÄÚÈÝ¡£
¸ÃÖ¸Äϲݰ¸ÐÞ¶©ÁË 2005 Äê 4 ÔÂÐû²¼µÄÌâΪ¡¶PDUFA ²úÆ·ÓÅÒìÉóÆÀ¹ÜÀíÔÔòºÍʵ¼ù¡·µÄÉóÆÀÖ°Ô±ºÍÐÐÒµÖ¸ÄÏ£¬ÕâÒ»ÐÞ¶©ÊÂÇéÊÇ FDA ×÷Ϊ´¦·½Ò©Ê¹ÓÃÕ߸¶·Ñ·¨°¸£¨PDUFA£©VI ºÍÉúÎïÀàËÆÒ©Ê¹ÓÃÕ߸¶·Ñ·¨°¸£¨BsUFA£©II µÄÒ»²¿·ÖÔÊÐí¾ÙÐеÄÖ¸ÄϸüС£
ÕûÀí£ºÊ¶ÁÖ-½·
²Î¿¼×ÊÁÏ
Final ANDA Submission Guidance Published Today - Lachman Consultants
Drug Competition Action Plan: FDA Issues One Draft, One Final Guidance - RAPS